Jan 9
|
FTSE 100 LIVE: Hays shares slide after 'difficult December', GSK in $1bn respiratory drug deal
|
Jan 9
|
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn deal
|
Jan 9
|
GSK strikes £1.1bn deal for asthma drugmaker
|
Jan 9
|
GSK Enters Agreement to Acquire Aiolos Bio
|
Jan 9
|
Trending tickers: Apple | Samsung | GSK | Jupiter
|
Jan 9
|
GSK Expands Respiratory Pipeline With Aiolos Bio Buy
|
Jan 5
|
Why Glaxo (GSK) is Poised to Beat Earnings Estimates Again
|
Dec 29
|
How Lowering The Price of a Common Asthma Drug Made It Harder to Get
|
Dec 29
|
Investing in GSK (LON:GSK) five years ago would have delivered you a 22% gain
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
Dec 22
|
GSK to cut US prices for Advair, Valtrex and Lamictal
|
Dec 21
|
Sunak hosts bosses for Business Council gathering
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
Dec 7
|
20 Countries with Free Health Care
|
Dec 4
|
Glaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
|
Dec 4
|
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
|
Dec 2
|
Boasting A 52% Return On Equity, Is GSK plc (LON:GSK) A Top Quality Stock?
|
Nov 27
|
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
|
Nov 27
|
3 Great Foreign Companies to Invest in Right Now
|
Nov 26
|
15 Best Drug Stocks To Invest In
|